Early experience of seven hepatocellular carcinoma cases treated with regorafenib

por Uchikawa, Shinsuke, Kawaoka, Tomokazu, Aikata, Hiroshi, Kodama, Kenichiro, Inagaki, Yuki, Hatooka, Masahiro, Morio, Kei, Nakahara, Takashi, Murakami, Eisuke, Hiramatsu, Akira, Tsuge, Masataka, Imamura, Michio, Kawakami, Yoshiiku, Chayama, Kazuaki
Publicado 2018

Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy

por Ohya, Kazuki, Kawaoka, Tomokazu, Namba, Maiko, Uchikawa, Shinsuke, Kodama, Kenichiro, Morio, Kei, Nakahara, Takashi, Murakami, Eisuke, Hiramatsu, Akira, Tsuge, Masataka, Yamauchi, Masami, Imamura, Michio, Chayama, Kazuaki, Aikata, Hiroshi
Publicado 2019

Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy

por Saeki, Issei, Yamasaki, Takahiro, Yamauchi, Yurika, Kawaoka, Tomokazu, Uchikawa, Shinsuke, Hiramatsu, Akira, Aikata, Hiroshi, Kobayashi, Kazufumi, Kondo, Takayuki, Ogasawara, Sadahisa, Chiba, Tetsuhiro, Kawano, Reo, Chayama, Kazuaki, Kato, Naoya, Takami, Taro
Publicado 2023

Skeletal Muscle Volume Is an Independent Predictor of Survival after Sorafenib Treatment Failure for Hepatocellular Carcinoma

por Saeki, Issei, Yamasaki, Takahiro, Yamauchi, Yurika, Takami, Taro, Kawaoka, Tomokazu, Uchikawa, Shinsuke, Hiramatsu, Akira, Aikata, Hiroshi, Kawano, Reo, Kobayashi, Kazufumi, Kondo, Takayuki, Ogasawara, Sadahisa, Chiba, Tetsuhiro, Chayama, Kazuaki, Kato, Naoya, Sakaida, Isao
Publicado 2021

Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment

por Yamasaki, Takahiro, Saeki, Issei, Yamauchi, Yurika, Matsumoto, Toshihiko, Suehiro, Yutaka, Kawaoka, Tomokazu, Uchikawa, Shinsuke, Hiramatsu, Akira, Aikata, Hiroshi, Kobayashi, Kazufumi, Kondo, Takayuki, Ogasawara, Sadahisa, Chiba, Tetsuhiro, Takami, Taro, Chayama, Kazuaki, Kato, Naoya, Sakaida, Isao
Publicado 2022

Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib

por Fujii, Yasutoshi, Ono, Atsushi, Hayes, C. Nelson, Aikata, Hiroshi, Yamauchi, Masami, Uchikawa, Shinsuke, Kodama, Kenichiro, Teraoka, Yuji, Fujino, Hatsue, Nakahara, Takashi, Murakami, Eisuke, Miki, Daiki, Okamoto, Wataru, Kawaoka, Tomokazu, Tsuge, Masataka, Imamura, Michio, Chayama, Kazuaki
Publicado 2021

A case of acute liver failure with echovirus infection diagnosed by a multi-virus real-time PCR system

por Yoshikawa, Yuki, Imamura, Michio, Morio, Kei, Yamaoka, Kenji, Ando, Yuwa, Kosaka, Yumi, Uchikawa, Shinsuke, Fujino, Hatsue, Nakahara, Takashi, Murakami, Eisuke, Yamauchi, Masami, Kawaoka, Tomokazu, Tsuge, Masataka, Hiramatsu, Akira, Hayes, C. Nelson, Aikata, Hiroshi, Wakita, Takaji, Katano, Harutaka, Chayama, Kazuaki
Publicado 2021

Successful Lenvatinib Re-challenge following Atezolizumab Plus Bevacizumab Combination Therapy Failure for Unresectable Hepatocellular Carcinoma

por Kosaka, Yumi, Kawaoka, Tomokazu, Kosaka, Masanari, Shirane, Yuki, Miura, Ryoichi, Murakami, Serami, Johira, Yusuke, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Kodama, Kenichiro, Uchikawa, Shinsuke, Fujino, Hatsue, Ohno, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Imamura, Michio, Aikata, Hiroshi
Publicado 2022

Benign Recurrent Intrahepatic Cholestasis Type 1 with Novel Nonsense Mutations in the ATP8B1 Gene

por Miura, Ryoichi, Kawaoka, Tomokazu, Imamura, Michio, Kosaka, Masanari, Johira, Yusuke, Shirane, Yuki, Murakami, Serami, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Kosaka, Yumi, Kodama, Kenichiro, Uchikawa, Shinsuke, Fujino, Hatsue, Ono, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Yamauchi, Masami, Hinoi, Takao, Aikata, Hiroshi
Publicado 2022

Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma

por Ando, Yuwa, Kawaoka, Tomokazu, Kosaka, Masanari, Shirane, Yuki, Johira, Yusuke, Miura, Ryoichi, Murakami, Serami, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Kosaka, Yumi, Uchikawa, Shinsuke, Kodama, Kenichiro, Fujino, Hatsue, Nakahara, Takashi, Ono, Atushi, Murakami, Eisuke, Yamauchi, Masami, Okamoto, Wataru, Takahashi, Shoichi, Imamura, Michio, Aikata, Hiroshi
Publicado 2022

Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study

por Nagaoki, Yuko, Hyogo, Hideyuki, Ando, Yuwa, Kosaka, Yumi, Uchikawa, Shinsuke, Nishida, Yuno, Teraoka, Yuji, Morio, Kei, Fujino, Hatsue, Ono, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Yamauchi, Masami, Okamoto, Wataru, Kawaoka, Tomokazu, Tsuge, Masataka, Hiramatsu, Akira, Miki, Daiki, Imamura, Michio, Takahashi, Shoichi, Chayama, Kazuaki, Aikata, Hiroshi
Publicado 2021

Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and...

por Kinami, Takahiro, Amioka, Kei, Kawaoka, Tomokazu, Uchikawa, Shinsuke, Yamasaki, Shintaro, Kosaka, Masanari, Johira, Yusuke, Yano, Shigeki, Naruto, Kensuke, Ando, Yuwa, Yamaoka, Kenji, Fujii, Yasutoshi, Fujino, Hatsue, Nakahara, Takashi, Ono, Atsushi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Miki, Daiki, Tsuge, Masataka, Imamura, Michio, Aikata, Hiroshi, Oka, Shiro
Publicado 2023

Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis

por Hiramatsu, Akira, Aikata, Hiroshi, Uchikawa, Shinsuke, Ohya, Kazuki, Kodama, Kenichiro, Nishida, Yuno, Daijo, Kana, Osawa, Mitsutaka, Teraoka, Yuji, Honda, Fumi, Inagaki, Yuki, Morio, Kei, Morio, Reona, Fujino, Hatsue, Nakahara, Takashi, Murakami, Eisuke, Yamauchi, Masami, Kawaoka, Tomokazu, Miki, Daiki, Tsuge, Masataka, Imamura, Michio, Tanaka, Junko, Chayama, Kazuaki
Publicado 2019

Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma

por Yamauchi, Masami, Ono, Atsushi, Ishikawa, Akira, Kodama, Kenichiro, Uchikawa, Shinsuke, Hatooka, Haruna, Zhang, Peiyi, Teraoka, Yuji, Morio, Kei, Fujino, Hatsue, Nakahara, Takashi, Murakami, Eisuke, Miki, Daiki, Kawaoka, Tomokazu, Tsuge, Masataka, Hiramatsu, Akira, Imamura, Michio, Hayes, Clair Nelson, Fujita, Masashi, Nakagawa, Hidewaki, Yasui, Wataru, Aikata, Hiroshi, Chayama, Kazuaki
Publicado 2020

Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice

por Ando, Yuwa, Kawaoka, Tomokazu, Kosaka, Masanari, Shirane, Yuki, Johira, Yusuke, Miura, Ryoichi, Murakami, Serami, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Kosaka, Yumi, Uchikawa, Shinsuke, Kodama, Kenichiro, Fujino, Hatsue, Nakahara, Takashi, Ono, Atsushi, Murakami, Eisuke, Yamauchi, Masami, Okamoto, Wataru, Takahashi, Shoichi, Imamura, Michio, Chayama, Kazuaki, Aikata, Hiroshi
Publicado 2021

Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma

por Yamauchi, Masami, Ono, Atsushi, Amioka, Kei, Fujii, Yasutoshi, Nakahara, Hikaru, Teraoka, Yuji, Uchikawa, Shinsuke, Fujino, Hatsue, Nakahara, Takashi, Murakami, Eisuke, Okamoto, Wataru, Miki, Daiki, Kawaoka, Tomokazu, Tsuge, Masataka, Imamura, Michio, Hayes, C. Nelson, Ohishi, Waka, Kishi, Takeshi, Kimura, Mizuki, Suzuki, Natsumi, Arihiro, Koji, Aikata, Hiroshi, Chayama, Kazuaki, Oka, Shiro
Publicado 2023

Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma

por Yano, Shigeki, Kawaoka, Tomokazu, Yamasaki, Shintaro, Johira, Yusuke, Kosaka, Masanari, Shirane, Yuki, Miura, Ryoichi, Amioka, Kei, Naruto, Kensuke, Yamaoka, Kenji, Fujii, Yasutoshi, Uchikawa, Shinsuke, Fujino, Hatsue, Ono, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Miki, Daiki, Tsuge, Masataka, Teraoka, Yuji, Kouno, Hirotaka, Takaki, Shintaro, Mori, Nami, Tsuji, Keiji, Oka, Shiro
Publicado 2023

Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib

por Yamaoka, Kenji, Kawaoka, Tomokazu, Aikata, Hiroshi, Ando, Yuwa, Kosaka, Yumi, Suehiro, Yosuke, Fujii, Yasutomo, Uchikawa, Shinsuke, Morio, Kei, Fujino, Hatsue, Nakahara, Takashi, Murakami, Eisuke, Yamauchi, Masami, Tsuge, Masataka, Hiramatsu, Akira, Imamura, Michio, Takahashi, Shoichi, Saeki, Yoshihiro, Kuroda, Shintaro, Kobayashi, Tsuyoshi, Ohdan, Hideki, Miyata, Yoshihiro, Okada, Morihito, Chayama, Kazuaki
Publicado 2021

Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma—Consideration of the Locations of Target Lesions

por Yano, Shigeki, Kimura, Tomoki, Kawaoka, Tomokazu, Kinami, Takahiro, Yamasaki, Shintaro, Johira, Yusuke, Kosaka, Masanari, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Yamaoka, Kenji, Fujii, Yasutoshi, Uchikawa, Shinsuke, Fujino, Hatsue, Ono, Atsushi, Nakahara, Takashi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Imamura, Michio, Hirokawa, Junichi, Nagata, Yasushi, Aikata, Hiroshi, Oka, Shiro
Publicado 2023

Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study

por Johira, Yusuke, Nakahara, Takashi, Kinami, Takahiro, Yamasaki, Shintaro, Kosaka, Masanari, Shirane, Yuki, Miura, Ryoichi, Murakami, Serami, Yano, Shigeki, Amioka, Kei, Naruto, Kensuke, Ando, Yuwa, Kosaka, Yumi, Kodama, Kenichiro, Uchikawa, Shinsuke, Fujino, Hatsue, Ono, Atsushi, Murakami, Eisuke, Okamoto, Wataru, Yamauchi, Masami, Kawaoka, Tomokazu, Hayes, C. Nelson, Tsuge, Masataka, Imamura, Michio, Aikata, Hiroshi, Oka, Shiro
Publicado 2023